Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Graft-Versus-Host Disease

Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Bone Marrow Transplantation volume 38, pages 351–357 (2006)Cite this article

Abstract

Chronic graft-versus-host disease (cGVHD) is the most common late complication of allogeneic hematopoietic cell transplantation (HCT) causing significant morbidity and mortality. The kidneys are not considered a target organ for cGVHD in humans, although animal models show renal damage. Renal involvement in patients with cGVHD, presenting as nephrotic syndrome (NS), has rarely been reported in patients who received allogeneic transplantation. Herein we describe, by far, the largest series of nine patients with NS associated with cGVHD, including two patients who received a reduced-intensity regimen. Pathological features of membranous nephropathy were the most common finding on renal biopsy. The clinical course of the NS was temporally associated with the classical features of cGVHD in all but one of the nine cases. The clinicopathologic features of NS in our series as well as reports in the literature demonstrate an immunopathologic process typical of antibody-mediated damage consistent with cGVHD. Treatment directed against antibody-mediated damage, such as anti-B-cell antibody may play an important role in ameliorating NS associated with cGVHD.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Ratanatharathorn V, Ayash L, Lazarus HM, Fu J, Uberti JP . Chronic graft-versus-host disease: clinical manifestation and therapy (Review) (126 refs). Hematopoietic Cell Transplant 2001; 28: 121–129.

    CAS  Google Scholar 

  2. Flowers ME, Parker PM, Johnston LJ, Matos AV, Storer B, Bensinger WI et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood 2002; 100: 415–419.

    Article  CAS  PubMed  Google Scholar 

  3. Scott MA, Gandhi MK, Jestice HK, Mahendra P, Bass G, Marcus RE . A trend towards an increased incidence of chronic graft-versus-host disease following allogeneic peripheral blood progenitor cell transplantation: a case controlled study. Hematopoietic Cell Transplant 1998; 22: 273–276.

    CAS  Google Scholar 

  4. Solano C, Martinez C, Brunet S, Tomas JF, Urbano-Ispizua A, Zuazu J et al. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or hematopoietic cell transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT. Hematopoietic Cell Transplant 1998; 22: 1129–1135.

    CAS  Google Scholar 

  5. Storek J, Gooley T, Siadak M, Bensinger WI, Maloney DG, Chauncey TR et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease (see comments). Blood 1997; 90: 4705–4709.

    CAS  PubMed  Google Scholar 

  6. Urbano-Ispizua A, Garcia-Conde J, Brunet S, Hernandez F, Sanz G, Petit et al. High incidence of chronic graft versus host disease after allogeneic peripheral blood progenitor cell transplantation. The Spanish Group of Allo-PBPCT. Haematologica 1997; 82: 683–689.

    CAS  PubMed  Google Scholar 

  7. Murphy WJ . Revisiting graft-versus-host disease models of autoimmunity: new insights in immune regulatory processes (comment). J Clin Invest 2000; 106: 745–747.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Greinix HT, Volc-Platzer B, Rabitsch W, Gmeinhart B, Guevara-Pineda C, Kalhs P et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood 1998; 92: 3098–3104.

    CAS  PubMed  Google Scholar 

  9. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading (Review) (11 refs). Hematopoietic Cell Transplant 1995; 15: 825–828.

    CAS  Google Scholar 

  10. Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267–276.

    CAS  PubMed  Google Scholar 

  11. Ratanatharathorn V, Karanes C, Lum LG, Uberti J, Dan ME, de Planque MM et al. Allogeneic hematopoietic cell transplantation in high-risk myeloid disorders using busulfan, cytosine arabinoside and cyclophosphamide (BAC). Hematopoietic Cell Transplant 1992; 9: 49–55.

    CAS  Google Scholar 

  12. Reynolds C, Ratanatharathorn V, Adams P, Braun T, Silver S, Ayash L et al. Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma. Hematopoietic Cell Transplant 2001; 27: 801–807.

    CAS  Google Scholar 

  13. Tutschka PJ, Copelan EA, Klein JP . Hematopoietic cell transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 1987; 70: 1382–1388.

    CAS  PubMed  Google Scholar 

  14. Ratanatharathorn V, Uberti J, Karanes C, Abella E, Lum LG, Momin F et al. Prospective comparative trial of autologous versus allogeneic hematopoietic cell transplantation in patients with non-Hodgkin's lymphoma. Blood 1994; 84: 1050–1055.

    CAS  PubMed  Google Scholar 

  15. Levine JE, Uberti JP, Ayash L, Reynolds C, Ferrara JL, Silver SM et al. Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy. Biol Blood Marrow Transplant 2003; 9: 189–197.

    Article  PubMed  Google Scholar 

  16. Barbara JA, Thomas AC, Smith PS, Gillis D, Ho JO, Woodroffe AJ . Membranous nephropathy with graft-versus-host disease in a hematopoietic cell transplant recipient. Clin Nephrol 1992; 37: 115–118.

    CAS  PubMed  Google Scholar 

  17. Gomez-Garcia P, Herrera-Arroyo C, Torres-Gomez A, Gomez-Carrasco J, Aljama-Garcia P, Lopez-Rubio F et al. Renal involvement in chronic graft-versus-host disease: a report of two cases. Hematopoietic Cell Transplant 1988; 3: 357–362.

    CAS  Google Scholar 

  18. Hiesse C, Goldschmidt E, Santelli G, Charpentier B, Machover D, Fries D . Membranous nephropathy in a hematopoietic cell transplant recipient. Am J Kidney Dis 1988; 11: 188–191.

    Article  CAS  PubMed  Google Scholar 

  19. Lin J, Markowitz GS, Nicolaides M, Hesdorffer CS, Appel GB, D'Agati VD et al. Membranous glomerulopathy associated with graft-versus-host disease following allogeneic stem cell transplantation. Report of 2 cases and review of the literature (Review) (24 refs). Am J Nephrol 2001; 21: 351–356.

    Article  CAS  PubMed  Google Scholar 

  20. Muller GA, Muller CA, Markovic-Lipkowski J, Bross-Bach U, Schmidt H, Ehninger G et al. Membranous nephropathy after hematopoietic cell transplantation in ciclosporin treatment. Nephron 1989; 51: 555–556.

    Article  CAS  PubMed  Google Scholar 

  21. Nergizoglu G, Keven K, Ates K, Ustun C, Tulunay O, Beksac M et al. Chronic graft-versus-host disease complicated by membranous glomerulonephritis. Nephrol Dialysis Transplant 1999; 14: 2461–2463.

    Article  CAS  Google Scholar 

  22. Ohsawa I, Ohi H, Fujita T, Endo M, Ito T, Sawada U et al. Glomerular and extraglomerular immune complex deposits in a hematopoietic cell transplant recipient. Am J Kidney Dis 2000; 36: E3.

    Article  CAS  PubMed  Google Scholar 

  23. Oliveira JS, Bahia D, Franco M, Balda C, Stella S, Kerbauy J . Nephrotic syndrome as a clinical manifestation of graft-versus-host disease (GVHD) in a marrow transplant recipient after cyclosporine withdrawal. Hematopoietic Cell Transplant 1999; 23: 99–101.

    CAS  Google Scholar 

  24. Rossi L, Cardarelli F, Vampa ML, Buzio C, Olivetti G . Membranous glomerulonephritis after haematopoietic cell transplantation for multiple myeloma (Review) (18 refs). Nephron 2001; 88: 260–263.

    Article  CAS  PubMed  Google Scholar 

  25. Sato N, Kishi K, Yagisawa K, Kasama J, Karasawa R, Shimada H et al. Nephrotic syndrome in a hematopoietic cell transplant recipient with chronic graft-versus-host disease. Hematopoietic Cell Transplant 1995; 16: 303–305.

    CAS  Google Scholar 

  26. Yorioka N, Taniguchi Y, Shimote K, Komo T, Yamakido M, Hyodo H et al. Membranous nephropathy with chronic graft-versus-host disease in a hematopoietic cell transplant recipient (letter). Nephron 1998; 80: 371–372.

    Article  CAS  PubMed  Google Scholar 

  27. Shi Q, Wu MH, Fujita Y, Ishida A, Wijelath ES, Hammond WP et al. Genetic tracing of arterial graft flow surface endothelialization in allogeneic marrow transplanted dogs. Cardiovas Surg 1999; 7: 98–105.

    Article  CAS  Google Scholar 

  28. Romagnani P, Lazzeri E, Mazzinghi B, Lassagni L, Guidi S, Bosi A et al. Nephrotic syndrome and renal failure after allogeneic stem cell transplantation: novel molecular diagnostic tools for a challenging differential diagnosis. Am J Kidney Dis 2005; 46: 550–556.

    Article  PubMed  Google Scholar 

  29. Storek J, Gooley T, Siadak M, Bensinger WI, Maloney DG, Chauncey TR et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 1997; 90: 4705–4709.

    CAS  PubMed  Google Scholar 

  30. Zaucha JM, Gooley T, Bensinger WI, Heimfeld S, Chauncey TR, Zaucha R et al. CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation. Blood 2001; 98: 3221–3227.

    Article  CAS  PubMed  Google Scholar 

  31. Remberger M, Beelen DW, Fauser A, Basara N, Basu O, Ringden O . Increased risk of extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation using unrelated donors. Blood 2005; 105: 548–551.

    Article  CAS  PubMed  Google Scholar 

  32. Pan L, Delmonte JJ, Jalonen CK, Ferrara JL . Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 1995; 86: 4422–4429.

    CAS  PubMed  Google Scholar 

  33. Mielcarek M, Martin PJ, Torok-Storb B . Suppression of alloantigen-induced T-cell proliferation by CD14+ cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood 1997; 89: 1629–1634.

    CAS  PubMed  Google Scholar 

  34. Krenger W, Ferrara JL . Graft-versus-host disease and the Th1/Th2 paradigm (review) (172 refs). Immunol Res 1996; 15: 50–73.

    Article  CAS  PubMed  Google Scholar 

  35. Graze PR, Gale RP . Chronic graft versus host disease: a syndrome of disordered immunity. Am J Med 1979; 66: 611–620.

    Article  CAS  PubMed  Google Scholar 

  36. De Wit D, Van Mechelen M, Zanin C, Doutrelepont JM, Velu T, Gerard C et al. Preferential activation of Th2 cells in chronic graft-versus-host reaction. J Immunol 1993; 150: 361–366.

    CAS  PubMed  Google Scholar 

  37. Anasetti C, Rybka W, Sullivan KM, Banaji M, Slichter SJ . Graft-v-host disease is associated with autoimmune-like thrombocytopenia (see comments). Blood 1989; 73: 1054–1058.

    CAS  PubMed  Google Scholar 

  38. Miklos DB, Kim HT, Zorn E, Hochberg EP, Guo L, Mattes-Ritz A et al. Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors. Blood 2004; 103: 353–359.

    Article  CAS  PubMed  Google Scholar 

  39. Ratanatharathorn V, Ayash L, Reynolds C, Silver S, Reddy P, Becker M et al. Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody. Biol Blood Marrow Transplant 2003; 9: 505–511.

    Article  CAS  PubMed  Google Scholar 

  40. Miklos DB, Kim HT, Miller KH, Guo L, Zorn E, Lee SJ et al. Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood 2005; 105: 2973–2978.

    Article  CAS  PubMed  Google Scholar 

  41. Emerson SG . GVHD and relapse: to B or not to B. Blood 2005; 105: 2627–2628.

    Article  CAS  Google Scholar 

  42. Ratanatharathorn V, Carson E, Reynolds C, Ayash LJ, Levine J, Yanik G et al. Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease. Ann Intern Med 2000; 133: 275–279.

    Article  CAS  PubMed  Google Scholar 

  43. Seconi J, Watt V, Ritchie DS . Nephrotic syndrome following allogeneic stem cell transplantation associated with increased production of TNF-alpha and interferon-gamma by donor T cells. Bone Marrow Transplant 2003; 32: 447–450.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology-Oncology, Department of Medicine, Blood and Marrow Transplantation Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA

    P Reddy, C Reynolds & S Silver

  2. Department of Pathology, University of Michigan Medical Center, Ann Arbor, MI, USA

    K Johnson

  3. Hematopoietic Stem Cell Transplantation Program, Karmanos Cancer Center, Wayne State University, Detroit, MI, USA

    J P Uberti, L Ayash & V Ratanatharathorn

  4. Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI, USA

    T M Braun

Authors
  1. P Reddy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J P Uberti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C Reynolds
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S Silver
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L Ayash
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. T M Braun
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. V Ratanatharathorn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P Reddy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reddy, P., Johnson, K., Uberti, J. et al. Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 38, 351–357 (2006). https://doi.org/10.1038/sj.bmt.1705446

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705446

Keywords

This article is cited by

Search

Advanced search

Quick links